Atlas Trials

Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy

Clinical trial NCT04183101 · RECRUITING

Trial details

NCT number
NCT04183101
Sponsor
Region Skane
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
C3 GlomerulopathyMembranoproliferative GlomerulonephritisComplement AbnormalityDense Deposit DiseaseC3 Glomerulonephritis
Start date
2020-10-01
Primary completion
2029-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.